Credit Suisse’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $227K | Buy |
16,052
+196
| +1% | +$2.78K | ﹤0.01% | 2879 |
|
|
2023
Q4 | $239K | Sell |
15,856
-630
| -4% | -$9.51K | ﹤0.01% | 2943 |
|
|
2023
Q3 | $260K | Sell |
16,486
-670
| -4% | -$10.6K | ﹤0.01% | 2965 |
|
|
2023
Q2 | $260K | Buy |
17,156
+4,757
| +38% | +$72K | ﹤0.01% | 3032 |
|
|
2023
Q1 | $180K | Buy |
12,399
+3,588
| +41% | +$52K | ﹤0.01% | 3120 |
|
|
2022
Q4 | $119K | Buy |
+8,811
| New | +$119K | ﹤0.01% | 3287 |
|
|
2022
Q3 | – | Sell |
-6
| Closed | – | – | 4275 |
|
|
2022
Q2 | $0 | Buy |
+6
| New | – | ﹤0.01% | 4299 |
|